Oncotarget
The cover for issue 38 of Oncotarget features Figure 3, "Summary of the time and cost for drug development (modified from DiMasi et al [2016]," by Katayama, et al.
Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy |
https://doi.org/10.18632/oncotarget.27745 Nancy D. Ebelt, Vic Zamloot, and Edwin R. Manuel |
3486-3488 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? |
https://doi.org/10.18632/oncotarget.27727 Erryk S. Katayama, Jonathan J. Hue, David L. Bajor, Lee M. Ocuin, John B. Ammori, Jeffrey M. Hardacre, and Jordan M. Winter |
3489-3501 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Podcast | Order a Reprint |
Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness |
https://doi.org/10.18632/oncotarget.27748 Ashley J. Smuder, Brandon M. Roberts, Michael P. Wiggs, Oh Sung Kwon, Jeung-Ki Yoo, Demetra D. Christou, David D. Fuller, Hazel H. Szeto, and Andrew R. Judge |
3502-3514 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Altered lung tissue lipidomic profile in caspase-4 positive non-small cell lung cancer (NSCLC) patients |
https://doi.org/10.18632/oncotarget.27724 Michela Terlizzi, Antonio Molino, Chiara Colarusso, Pasquale Somma, Ilaria De Rosa, Jacopo Troisi, Giovanni Scala, Rosario Salvi, Aldo Pinto, and Rosalinda Sorrentino |
3515-3525 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
A low psoas muscle volume is associated with a poor prognosis in penile cancer |
https://doi.org/10.18632/oncotarget.27719 Daiji Takkamoto, Takashi Kawahara, Takashi Tokita, Jun Kasuga, Yasushi Yumura, and Hiroji Uemura |
3526-3530 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies |
https://doi.org/10.18632/oncotarget.27730 Fleury Augustin Nsole Biteghe, Neelakshi Mungra, Nyangone Ekome Toung Chalomie, Jean De La Croix Ndong, Jean Engohang-Ndong, Guillaume Vignaux, Eden Padayachee, Krupa Naran, and Stefan Barth |
3531-3557 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Correction: Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion |
https://doi.org/10.18632/oncotarget.27754 Tzu-Hsien Tsai, Cheng-Jei Lin, Sarah Chua, Sheng-Ying Chung, Cheng-Hsu Yang, Meng-Shen Tong, and Chi-Ling Hang |
3558-3558 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC